Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1CNS 1Breast 1

Conditions

Lung Neoplasms 1Liver Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Carboplatin 5Filgrastim 4Thiotepa 3Temozolomide 3Radiotherapy 3Cyclophosphamide 3sargramostim 2fludarabine 2aldesleukin 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Busulfan 2sodium thiosulfate 1pembrolizumab 1ixabepilone 1fludarabine phosphate 1etoposide phosphate 1erythromycin propionate-N-acetylcysteinate 1brodalumab 1Topotecan 1Thrombopoietin 1Tamoxifen 1Stem Cell Transplantation 1Sevoflurane 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Quality of Life 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Mesothelin × CNS × Clear all
NCT04842812 2024-06-25

Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors

Second Affiliated Hospital of Guangzhou Medical University

Phase 1 Recruiting
40 enrolled
BreastCNSGastrointestinalThoracic

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡